<?xml version="1.0" encoding="UTF-8"?>
<p id="P28">Median OS was not reached in any dosing cohort (range for all patients was 86 to 1324 days) (
 <xref rid="F2" ref-type="fig">Figure 2</xref>), and estimated 1-year survival rates in the 7-day and 14-day dosing cohorts were 86% and 81%, respectively.
</p>
